These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28718335)

  • 1. Variability of performance status assessment between patients with hematologic malignancies and their physicians.
    Leal AD; Allmer C; Maurer MJ; Shanafelt TD; Cerhan JR; Link BK; Thompson CA
    Leuk Lymphoma; 2018 Mar; 59(3):695-701. PubMed ID: 28718335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between physician and patient assessment of performance status and survival in a large cohort of patients with haematologic malignancies.
    Liu MA; Hshieh T; Condron N; Wadleigh M; Abel GA; Driver JA
    Br J Cancer; 2016 Sep; 115(7):858-61. PubMed ID: 27552440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer.
    Neeman E; Gresham G; Ovasapians N; Hendifar A; Tuli R; Figlin R; Shinde A
    Oncologist; 2019 Dec; 24(12):e1460-e1466. PubMed ID: 31227648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should patient-rated performance status affect treatment decisions in advanced lung cancer?
    Dajczman E; Kasymjanova G; Kreisman H; Swinton N; Pepe C; Small D
    J Thorac Oncol; 2008 Oct; 3(10):1133-6. PubMed ID: 18827609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer.
    Schnadig ID; Fromme EK; Loprinzi CL; Sloan JA; Mori M; Li H; Beer TM
    Cancer; 2008 Oct; 113(8):2205-14. PubMed ID: 18780322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Functionality Assessment Flowchart (FAF): a new simple and reliable method to measure performance status with a high percentage of agreement between observers.
    Paiva CE; Siquelli FA; Santos HA; Costa MM; Massaro DR; Lacerda DC; Nunes JS; de Pádua Souza C; Paiva BS
    BMC Cancer; 2015 Jul; 15():501. PubMed ID: 26142726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurse and physician inter-rater agreement of three performance status measures in palliative care outpatients.
    Zimmermann C; Burman D; Bandukwala S; Seccareccia D; Kaya E; Bryson J; Rodin G; Lo C
    Support Care Cancer; 2010 May; 18(5):609-16. PubMed ID: 19629537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-rater reliability in performance status assessment among health care professionals: a systematic review.
    Chow R; Chiu N; Bruera E; Krishnan M; Chiu L; Lam H; DeAngelis C; Pulenzas N; Vuong S; Chow E
    Ann Palliat Med; 2016 Apr; 5(2):83-92. PubMed ID: 27121736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple prognostic model for patients with advanced cancer based on performance status.
    Jang RW; Caraiscos VB; Swami N; Banerjee S; Mak E; Kaya E; Rodin G; Bryson J; Ridley JZ; Le LW; Zimmermann C
    J Oncol Pract; 2014 Sep; 10(5):e335-41. PubMed ID: 25118208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
    Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
    PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution.
    Buccheri G; Ferrigno D; Tamburini M
    Eur J Cancer; 1996 Jun; 32A(7):1135-41. PubMed ID: 8758243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations and prognostic implications of Eastern Cooperative Oncology Group performance status and tumoral LINE-1 methylation status in stage III colon cancer patients.
    Chen D; Wen X; Song YS; Rhee YY; Lee TH; Cho NY; Han SW; Kim TY; Kang GH
    Clin Epigenetics; 2016; 8():36. PubMed ID: 27051466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
    Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
    Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
    Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
    Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Analysis of Advanced HCC Treated with Radioembolization: Comparing Impact of Clinical Performance Status Versus Vascular Invasion/Metastases.
    Ali R; Gabr A; Abouchaleh N; Al Asadi A; Mora RA; Kulik L; Abecassis M; Riaz A; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):260-269. PubMed ID: 28879621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified Comorbidity Score and Eastern Cooperative Oncology Group Performance Score Predicts Survival in Patients Receiving Organ-preserving Treatment for Bladder Cancer.
    Manig L; Käsmann L; Janssen S; Schild SE; Rades D
    Anticancer Res; 2017 May; 37(5):2693-2696. PubMed ID: 28476846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥ 75 years after radical cystectomy for treatment of bladder cancer.
    Hara T; Matsuyama H; Kamiryo Y; Hayashida S; Yamamoto N; Nasu T; Joko K; Baba Y; Suga A; Yamamoto M; Aoki A; Takai K; Yoshihiro S; Konishi M; Sakano S; Imoto K; Tei Y; Yamaguchi S; Yano S;
    Int J Clin Oncol; 2016 Feb; 21(1):139-47. PubMed ID: 26077140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance status assessment in cancer patients. An inter-observer variability study.
    Sørensen JB; Klee M; Palshof T; Hansen HH
    Br J Cancer; 1993 Apr; 67(4):773-5. PubMed ID: 8471434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, multicenter cohort study to validate a simple performance status-based survival prediction system for oncologists.
    Yamada T; Morita T; Maeda I; Inoue S; Ikenaga M; Matsumoto Y; Baba M; Sekine R; Yamaguchi T; Hirohashi T; Tajima T; Tatara R; Watanabe H; Otani H; Takigawa C; Matsuda Y; Ono S; Ozawa T; Yamamoto R; Shishido H; Yamamoto N
    Cancer; 2017 Apr; 123(8):1442-1452. PubMed ID: 27926777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma].
    Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.